[ 1 ]
Symptoms
Diagnosis
Treatment
Common Questions & Answers
More than 99 percent of hoi polloi with prostate cancer that does n’t scatter from the original situation of growth inhabit for five years or longer compare to those who do n’t have malignant neoplastic disease , according to the American Cancer Society .
Warning signs of early prostate cancer let in need to urinate often ( peculiarly at night ) , weak , painful , or burn down water , and line in the pee or semen . However , prostate gland cancer does n’t always cause symptom . steady testing can rule it out .
This depends on the stage and eccentric of Crab . Delaying discussion for lower - stage prostate gland cancer that has not spread may not increase the endangerment of death . Cancer that spreads from the prostate has risks affecting other organs .
stage track prostate Crab ’s spread and severity . Stage 1 and 2 cancers have stay in the prostate gland , stage 3 mean Crab has attain nearby structures , and stage 4 has spread to other harmonium near the prostate gland .
Living With
News
Christopher Wolter , MD , is an assistant professor in urology atMayo Clinicin Phoenix , Arizona . He has been in practice session since 2008 , specializing in the expanse of urinary incontinence , pelvic electric organ prolapse , urologic reconstruction , urologic prosthetics , mail prostate cancer survivorship , cavernous dysfunction , neurourology and neuromodulation , and overall functional considerations of urogenital health .
Dr. Wolter has been heavily convoluted in urologic education . He spent the last 12 years heavily involved in resident education and leadership for his section , including the last eight years as urology residency program conductor . He presently serve well as the director of urologic education for the preclinical and clinical rotations for the Mayo Clinic Alix School of Medicine Phoenix , Arizona , campus .
Wolter completed his undergraduate and medical education at the University of Illinois . He then completed his urology abidance at Tulane University in New Orleans , follow by a fellowship in female pelvic medicine and rehabilitative urology at Vanderbilt University in Nashville , Tennessee .
Conor E. Steuer , MD , is medical oncologist specializing in the care of aerodigestive cancers , mesothelioma , and thymic malignancies and an assistant prof in the department of haematology and medical oncology at the Emory University School of Medicine in Atlanta . He fall in the clinical staff atEmory ’s Winship Cancer Instituteas a practicing doc in July 2015 . He presently serves as chair of the Lung and Aerodigestive Malignancies Working Group and is a phallus of the Discovery and Developmental Therapeutics Research Program at Winship .
Dr. Steuer have his medical arcdegree from the New York University School of Medicine in 2009 . He fill in his postdoctoral training as a fellow in the department of hematology and medical oncology at the Emory University School of Medicine , where he was chief bloke in his last year .
He has been active in inquiry including in clinical tribulation development , database analyses , and probe of molecular biomarkers . He is interested in investigating the molecular biota and genomics of thoracic and point and neck tumors for be able to further the care of these patient population . Additionally , he has taken an interest in utilizing national databases to do clinical outcomes enquiry , as well as further investigate rarefied forms of thoracic Crab .
Steuer ’s work has been published in many leading journals , such asCancer , theJournal of Thoracic Oncology , andLung Cancer , and has been presented at multiple international conference .
Daniel Landau , MD , is a magisterial board - certified hematologist - oncologist with a career that has spanned two lofty institution : the Orlando Health Cancer Institute and the Medical University of South Carolina . With a specialized pastime in GU oncology and hematology , he has been at the forefront of managing both benignant and malignant weather condition .
Dr. Landau is a initiate figure in integrating modern technology into oncology , having swear out as a director of telemedicine services . Under his leaders , multipleinnovativesystems have been designed and pilot , all with a singular focus : enhancing the patient experience .
Beyond his clinical and technical endeavors , Landau is deeply attached to medical Education Department . He has consecrate significant time and expertise to nurturing the skill of medical students , residents , and feller , ensuring that the fire of knowledge and compassion burning hopeful in the next genesis of oncologists .
ALL PROSTATE CANCER ARTICLES
